Found 436 chains in Genus chains table. Displaying 51 - 100. Applied filters: Proteins

Search results query: JmjN

Total Genus Sequence Length pdb Title
86 318 6bgzA Linked kdm5a jmj domain bound to the inhibitor 2-((2-chlorophenyl)(2-(1-methyl-1h-imidazol-2-yl)ethoxy)methyl)-1h-pyrrolo[3,2-b]pyridine-7-carboxylic acid (compound n47)
88 317 6bh5A Linked kdm5a jmj domain bound to the inhibitor 2-((2-chlorophenyl)(3-(piperidin-1-yl)propoxy)methyl)-1h-pyrrolo[3,2-b]pyridine-7-carboxylic acid (compound n48)
88 318 6bgvA Linked kdm5a jmj domain bound to the inhibitor 2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)-1l2-pyrrolo[3,2-b]pyridine-7-carboxylic acid (compound n40)
84 318 6bh4A Linked kdm5a jmj domain bound to the inhibitor 5-(1-(tert-butyl)-1h-pyrazol-4-yl)-6-isopropyl-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile (compound n75/cpi-48)
87 318 6bgwA Linked kdm5a jmj domain bound to the inhibitor 2-((2-chlorophenyl)(2-(4,4-difluoropiperidin-1-yl)ethoxy)methyl)-1h-pyrrolo[3,2-b]pyridine-7-carboxylic acid(compound n41)
86 318 6bh1A Linked kdm5a jmj domain bound to the inhibitor (s)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)-1l2-pyrrolo[3,2-b]pyridine-7-carboxylic acid (compound n52)
148 547 5yknA Crystal structure of arabidopsis thaliana jmj14 catalytic domain
158 547 5ykoA Crystal structure of arabidopsis thaliana jmj14 catalytic domain in complex with nog and h3k4me3 peptide
105 345 5vgiA Crystal structure of kdm4 with the small molecule inhibitor qc6352
108 350 5vmpA Crystal structure of human kdm4 with small molecule inhibitor qc5714
107 350 5f37A Crystal structure of human kdm4a in complex with compound 58
161 774 5cehA Structure of histone lysine demethylase kdm5a in complex with selective inhibitor
145 462 5a3nA Crystal structure of human plu-1 (jarid1b) in complex with kdoam25a
144 463 5a3pA Crystal structure of the catalytic domain of human plu1 (jarid1b).
144 458 5a1fA Crystal structure of the catalytic domain of plu1 in complex with n-oxalylglycine.
150 462 5a3tA Crystal structure of human plu-1 (jarid1b) in complex with kdm5-c49 (2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl) isonicotinic acid).
109 349 4uraA Crystal structure of human jmjd2a in complex with compound 14a
99 327 4d6sA Crystal structure of human jmjd2d in complex with n-oxalylglycine and bound 5,6-dimethylbenzimidazole
100 323 4d6rA Crystal structure of human jmjd2d in complex with n-oxalylglycine and bound o-toluenesulfonamide
104 330 4d6qA Crystal structure of human jmjd2d in complex with 2,4-pdca
103 348 4bisA Jmjd2a complexed with 8-hydroxyquinoline-4-carboxylic acid
107 348 4ai9A Jmjd2a complexed with daminozide
106 345 3u4sA Histone lysine demethylase jmjd2a in complex with t11c peptide substrate crosslinked to n-oxalyl-d-cysteine
107 351 3rvhA Crystal structure of jmjd2a complexed with inhibitor
106 345 2q8cA Crystal structure of jmjd2a in ternary complex with an histone h3k9me3 peptide and 2-oxoglutarate
105 344 2q8eA Specificity and mechanism of jmjd2a, a trimethyllysine-specific histone demethylase
100 347 2q8dA Crystal structure of jmj2d2a in ternary complex with histone h3-k36me2 and succinate
147 774 5v9tA Crystal structure of selective pyrrolidine amide kdm5a inhibitor n-{(3r)-1-[3-(propan-2-yl)-1h-pyrazole-5-carbonyl]pyrrolidin-3-yl}cyclopropanecarboxamide (compound 48)
158 774 5v9pA Crystal structure of pyrrolidine amide inhibitor [(3s)-3-(4-bromo-1h-pyrazol-1-yl)pyrrolidin-1-yl][3-(propan-2-yl)-1h-pyrazol-5-yl]methanone (compound 35) in complex with kdm5a
107 348 5tvrA Jmjd2a in complex with ni(ii) and alpha-ketoglutarate
104 348 5tvsA Jmjd2a in complex with ni(ii)
104 331 5pirA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 40)
105 331 5pmwA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 190)
104 331 5pivA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 44)
105 331 5pk1A Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 86)
104 330 5phhA Pandda analysis group deposition -- crystal structure of jmjd2d in complex with n09457a
106 331 5pm9A Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 167)
103 331 5pjwA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 81)
104 331 5pjqA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 75)
103 331 5pktA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 114)
107 331 5ph5A Pandda analysis group deposition -- crystal structure of jmjd2d in complex with n09724a
103 331 5pidA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 26)
103 331 5pk7A Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 92)
104 331 5plpA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 146)
105 331 5phcA Pandda analysis group deposition -- crystal structure of jmjd2d in complex with n09649a
104 331 5phkA Pandda analysis group deposition -- crystal structure of jmjd2d in complex with n09720a
104 331 5pjkA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 69)
103 331 5phuA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 7)
104 331 5pkaA Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 95)
103 331 5pj9A Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 58)